Implantable lens developer STAAR will fund the repurchase using cash on hand and money generated from business operations.

GE HealthCare has gained 501(k) clearance from the US Food and Drug Administration (FDA) for its CleaRecon DL technology.

Ophthalmic technology developer Intalight has received the CE mark for its DREAM OCT (optical coherence tomography) platform ...

The FDA has granted breakthrough device designation for Elucent Medical’s EnVisio X1 In-Body Spatial Intelligence System.

Abbott's REFLECT studies indicate that FreeStyle Libre use is linked to a decrease in hospitalisation risk for heart ...

Artificial Intelligence (AI) is now used throughout clinical trials, from recruitment to analysis – but are regulators ...